Cargando…
The BCR-ABL1 Kinase Bypasses Selection for the Expression of a Pre–B Cell Receptor in Pre–B Acute Lymphoblastic Leukemia Cells
The BCR-ABL1 kinase expressed in acute lymphoblastic leukemia (ALL) drives malignant transformation of human pre–B cells. Comparing genome-wide gene expression profiles of BCR-ABL1 (+) pre–B ALL and normal bone marrow pre–B cells by serial analysis of gene expression, many genes involved in pre–B ce...
Autores principales: | Klein, Florian, Feldhahn, Niklas, Harder, Lana, Wang, Hui, Wartenberg, Maria, Hofmann, Wolf-Karsten, Wernet, Peter, Siebert, Reiner, Müschen, Markus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213306/ https://www.ncbi.nlm.nih.gov/pubmed/14993251 http://dx.doi.org/10.1084/jem.20031637 |
Ejemplares similares
-
Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells
por: Feldhahn, Niklas, et al.
Publicado: (2005) -
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
por: Kaur, Pavinder, et al.
Publicado: (2007) -
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells
por: Feldhahn, Niklas, et al.
Publicado: (2007) -
Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
por: Feldhahn, Niklas, et al.
Publicado: (2012) -
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
por: Fei, Fei, et al.
Publicado: (2010)